Premier Research Appoints John Cargill as Chief Commercial Officer

MORRISVILLE, NC, March 11, 2024 – Premier Research is pleased to announce the appointment of John Cargill as its new Chief Commercial Officer. In this role, Mr. Cargill will be responsible for driving the organization’s commercial strategy including enhancements to the customer experience and supporting corporate growth.

Mr. Cargill brings a wealth of experience and expertise to Premier Research, having previously served in key leadership roles at Caidya (formerly Clinipace), Fortrea (formerly Covance), ICON, Syneos Health, and ThermoFisher Scientific. His experience spans clinical research, functional service, telemedicine, and eClinical solutions. Mr. Cargill has dedicated his career to advancing patient-centric healthcare and worked tirelessly to support initiatives that improve the research and development process for both sponsors and patients.

“We are thrilled to welcome John to our executive team as Chief Commercial Officer. His unique blend of industry knowledge, commercial experience, and patient-focused strategy will provide a valuable perspective as we evolve our strategic vision and deliver the most effective service for our customers across the biotech, MedTech, and specialty pharma industries,” said Premier Research Chief Executive Officer, John Ratliff.

John Cargill expressed excitement about joining Premier Research, “I am honored to join Premier Research during this exciting growth phase. I look forward to collaborating with the talented team to support the ongoing success of the company. Together, we will create lasting value for our customers and stakeholders and bring innovative new therapies to patients around the world.”

About Premier Research

Premier Research, a global clinical research, product development, and consulting company, is dedicated to helping biotech, specialty pharma, and medtech innovators transform life-changing ideas and breakthrough science into new medical treatments.

Premier Research is Built for Biotech^TM and specializes in the use of innovative technologies for smart study design and trial management to deliver clean, conclusive data to sponsors.

Whether it’s developing product lifecycle strategies, reducing clinical development cycle timelines, securing access to patients, navigating global regulations, maximizing the impact of limited rare disease data, or providing expertise in specific therapeutic areas, Premier Research is committed to helping its customers answer the unmet needs of patients across a broad range of medical conditions. Visit premier-research.com.